Literature DB >> 11825921

Laboratory confirmation of meningococcal disease in Scotland, 1993-9.

S C Clarke1, J Reid, L Thom, B C Denham, G F S Edwards.   

Abstract

AIMS: To describe the laboratory confirmation of meningococcal disease, using culture and non-culture based techniques, between 1993 and 1999 as part of a national service in Scotland.
METHODS: Samples from patients with suspected meningococcal disease in Scotland were analysed by culture and non-culture based techniques to gain a laboratory confirmation of disease. Data were analysed to establish the number of disease cases, the serogroups of the organisms involved, and the importance of the techniques used.
RESULTS: Between 1993 and 1999, there was a total of 1749 notified cases of meningococcal disease in Scotland. Culture based methods provided a laboratory confirmation of 788 cases whereas non-culture techniques confirmed 461 cases.
CONCLUSIONS: Non-culture techniques were a useful addition to culture based techniques in Scotland and improved the dataset required for public health management, disease surveillance, and vaccine policy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11825921      PMCID: PMC1769563          DOI: 10.1136/jcp.55.1.32

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Meningococcal conjugate vaccines: new opportunities and new challenges.

Authors:  M C Maiden; B G Spratt
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

2.  Rapid serogroup switching in Neisseria meningitidis.

Authors:  U Vogel; H Claus; M Frosch
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Implications for the serogroup incidence of meningococcal disease after the introduction of the MenC vaccine.

Authors:  S C Clarke; G F Edwards
Journal:  Scott Med J       Date:  2000-06       Impact factor: 0.729

Review 4.  Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.

Authors:  C E Frasch; W D Zollinger; J T Poolman
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

5.  The carrier state: Neisseria meningitidis.

Authors:  C V Broome
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

6.  ELISA test for antimeningococcal IgG and IgM antibodies: application to epidemiology and diagnosis.

Authors:  B E Kristiansen; T Flaegstad; E S Falk; A Halstensen
Journal:  Scand J Infect Dis       Date:  1992

7.  Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study.

Authors:  K R Neal; J S Nguyen-Van-Tam; N Jeffrey; R C Slack; R J Madeley; K Ait-Tahar; K Job; M C Wale; D A Ala'Aldeen
Journal:  BMJ       Date:  2000-03-25

8.  Serological grouping of meningococci and detection of antigen in cerebrospinal fluid by coagglutination.

Authors:  J Eldridge; E M Sutcliffe; J D Abbott; D M Jones
Journal:  Med Lab Sci       Date:  1978-01

9.  Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA.

Authors:  M Guiver; R Borrow; J Marsh; S J Gray; E B Kaczmarski; D Howells; P Boseley; A J Fox
Journal:  FEMS Immunol Med Microbiol       Date:  2000-06

10.  Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: report of a 1997 survey. Meningococcal meningitis: 1997 survey report.

Authors:  L Ragunathan; M Ramsay; R Borrow; M Guiver; S Gray; E B Kaczmarski
Journal:  J Infect       Date:  2000-01       Impact factor: 6.072

View more
  5 in total

1.  Identification of Neisseria meningitidis serogroups Y and W135 by siaD nucleotide sequence analysis.

Authors:  C Lewis; S C Clarke
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

Review 2.  Genotypic characterization of Neisseria meningitidis using Pyrosequencing.

Authors:  Matthew A Diggle; Stuart C Clarke
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

3.  Increased genetic diversity of Neisseria meningitidis isolates after the introduction of meningococcal serogroup C polysaccharide conjugate vaccines.

Authors:  Mathew A Diggle; Stuart C Clarke
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Epidemiology of two decades of invasive meningococcal disease in the Republic of Ireland: an analysis of national surveillance data on laboratory-confirmed cases from 1996 to 2016.

Authors:  D Bennett; P O'Lorcain; S Morgan; S Cotter; M Cafferkey; R Cunney
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

5.  Specific PCR Assay for Rapid and Direct Detection of Neisseria meningitidis in Cerebrospinal Fluid Specimens.

Authors:  M Qurbanalizadegan; R Ranjbar; Ra Ataee; M Hajia; Z Goodarzi; S Farshad; N Jonaidi Jafari; Y Panahi; H Kohanzad; M Rahbar; H Ghadimi; M Izadi
Journal:  Iran J Public Health       Date:  2010-12-31       Impact factor: 1.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.